FDA Warning Letter — NeuroField, Inc.
The FDA took a Warning Letter action against NeuroField, Inc. on February 28, 2022 (Santa Barbara, CA). The action was issued by CDRH and concerns devices products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- NeuroField, Inc.
- Date
- February 28, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Center
- CDRH
- Location
- Santa Barbara, CA (United States)